Cancer Family
Benign Nervous System Neoplasm
CI-CAN-00000084Explore in graph →
Non-malignant62 active trials2 evidence items
- NCIt
- C4789
Loading cancer entity…
Cancer Family
CI-CAN-00000084Explore in graph →
Clinical trials
232 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT03741101 | Treatment of NF1-related Plexiform Neurofibroma With Trametinib(plexifpc) | unknown | Phase 2 | 15 | Region SkaneOTHER | 1 | Apr 11, 2024 | clinicaltrials |
| NCT04163419 | Phase 2 Study of Tanezumab in Subjects With Moderate to Severe Pain Due to Schwannomatosis | unknown | Phase 2 | 9 | Massachusetts General HospitalOTHER | 1 | Mar 13, 2024 | clinicaltrials |
| NCT04801953 | Nimodipine in Vestibular Schwanommas | unknown | Phase 2 | 30 | Medical University of ViennaOTHER | 1 | Oct 19, 2023 | clinicaltrials |
| NCT03393689 | RGD PET/MRI in Sporadic Vestibular Schwannoma | unknown | Phase 2 | 40 | Rigshospitalet, DenmarkOTHER | 1 | Jan 10, 2018 | clinicaltrials |
Data updated 23 days agoSource updated Apr 11, 2024source: clinicaltrials